netFormulary NHS
NHS Herefordshire Clinical Commissioning Group
Wye Valley NHS Trust
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
08.02.03  Expand sub section  Anti-lymphocyte monoclonal antibodies
Rituximab (MabThera)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
 
   
Rituximab (MabThera)
(Subcutaneous injection)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
 
   
Rituximab (Truxima)
(Biosimilar)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
 
   
 ....
 Non Formulary Items
Alemtuzumab  (Lemtrada)

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA312: Alemtuzumab for relapsing‑remitting multiple sclerosis
 
Alemtuzumab  (MabCampath)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
 
Obinutuzumab  (Gazyvaro )

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA343: Obinutuzumab with chlorambucil for CLL
Link  NICE TA472: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab
Link  NICE TA513:Obinutuzumab for untreated advanced follicular lymphoma
 
Ofatumumab  (Arzerra)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA344: Ofatumumab with chlorambucil or bendamustine for CLL
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Suitable for use in primary care  

Amber

Specialist initiation. Shared care in place  

Red

Red do not use..  

Advice

Some formulations restricted  

Black

NICE "Do not do"  

Green 1

1st line option  

Green 2

2nd line option  

Green 3

3rd line option only  

Not Recomended / Black

Low Value Medicine not recommended for use - see NHSE guidelines  

OTC

This preparation should be bought over the counter for self-care  

Red Amber

Check product description for traffic light status  

Red Black

Low Value Medicine  

netFormulary